Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- Check6 days agoChange DetectedAdded revision note: Revision: v3.5.2. Removed references to cystic fibrosis, related topics, MedlinePlus Genetics, and Revision: v3.5.0.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded related topics: Cystic fibrosis and MedlinePlus Genetics to the related topics section.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now shows Revision: v3.4.3, and related-topic links such as Cystic Fibrosis related topics and MedlinePlus Genetics were removed.SummaryDifference0.2%

- Check63 days agoChange DetectedAdded related topics links for Cystic fibrosis and MedlinePlus Genetics. These are supplementary navigation aids and do not alter core study content or decisions about participation.SummaryDifference0.2%

- Check70 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding lapse notice and related topics such as Cystic fibrosis and Revision: v3.4.1.SummaryDifference0.6%

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.